eISSN 2508-7576
pISSN 2508-6235
pISSN 2508-6235
-
About the JOMES
-
Article
-
Online First
-
Subjects
-
For Contributors
-
e-Submission
✕
Articles
Medication >
2
714
394
Original Article 2024-03-30
Obesity as a Limiting Factor for Remote Ischemic Postconditioning-Mediated Neuroprotection after Stroke
Klaudia Kotorová, Jana Končeková, Miroslav Gottlieb, Martin Bona, Petra Bonová
J Obes Metab Syndr 2024; 33(1): 76-87
1
1032
348
Editorial 2023-12-30
The Transformative Impact of New Anti-Obesity Medications: A Paradigm Shift in Medical Practice?
Arya M. Sharma 
J Obes Metab Syndr 2023; 32(4): 285-288
10
4882
2192
Review 2023-06-30
Approved Anti-Obesity Medications in 2022 KSSO Guidelines and the Promise of Phase 3 Clinical Trials: Anti-Obesity Drugs in the Sky and on the Horizon
Eonju Jeon, Ki Young Lee , Kyoung-Kon Kim
, Kyoung-Kon Kim J Obes Metab Syndr 2023; 32(2): 106-120
0
888
400
Editorial 2023-06-30
The Prevalence of Abdominal Obesity and Metabolic Syndrome in Korean Children and Adolescents
Ja Hyang Cho
J Obes Metab Syndr 2023; 32(2): 103-105
33
10003
3511
Review 2023-03-30
Efficacy and Safety of Tirzepatide in Type 2 Diabetes and Obesity Management
Rachel Sinha, Dimitris Papamargaritis , Jack A. Sargeant, Melanie J. Davies
, Jack A. Sargeant, Melanie J. DaviesJ Obes Metab Syndr 2023; 32(1): 25-45
5
2370
506
Original Article 2022-09-30
Adherence to and Dropout from Liraglutide 3.0 mg Obesity Treatment in a Real-World Setting
Hae-Jin Ko, Jin-Wook Kim, Soo Lim
J Obes Metab Syndr 2022; 31(3): 254-262
16
9034
2876
Review 2022-03-30
The Upcoming Weekly Tides (Semaglutide vs. Tirzepatide) against Obesity: STEP or SURPASS?
Han Na Jung, Chang Hee Jung
J Obes Metab Syndr 2022; 31(1): 28-36
9
5056
880
Original Article 2021-12-30
Effect of Sodium-Glucose Cotransporter 2 Inhibitors on Weight Reduction in Overweight and Obese Populations without Diabetes: A Systematic Review and a Meta-Analysis
Yun Kyung Cho, Ye-Jee Kim, Chang Hee Jung
J Obes Metab Syndr 2021; 30(4): 336-344
5
2599
718
Review 2021-09-30
Incretin Hormones: Pathophysiological Risk Factors and Potential Targets for Type 2 Diabetes
Jared Rosenberg, Jordan Jacob, Priya Desai, Jeremy Park, Lorin Donovan, Joon Young Kim
J Obes Metab Syndr 2021; 30(3): 233-247
7
2918
1032
Review 2021-09-30
Unravelling Polycystic Ovary Syndrome and Its Comorbidities
Kyung-Wook Kim
J Obes Metab Syndr 2021; 30(3): 209-221
35
10367
4086
Review 2021-09-30
Next Generation Antiobesity Medications: Setmelanotide, Semaglutide, Tirzepatide and Bimagrumab: What do They Mean for Clinical Practice?
Donna H. Ryan
J Obes Metab Syndr 2021; 30(3): 196-208
8
3770
854
Review 2021-06-30
Oxytocin: A Potential Therapeutic for Obesity
Soo Min Hong, Jeong-Kyung Ko, Jung-Joon Moon, Youl-Ri Kim
J Obes Metab Syndr 2021; 30(2): 115-123
18
4319
1259
Review 2021-03-30
Side Effects Associated with Liraglutide Treatment for Obesity as Well as Diabetes
Young-Gyun Seo
J Obes Metab Syndr 2021; 30(1): 12-19
20
5719
2060
Review 2021-03-30
Menthol to Induce Non-shivering Thermogenesis via TRPM8/PKA Signaling for Treatment of Obesity
Owen Davis Sanders , Jayalekshmi Archa Rajagopal, Lekshmy Rajagopal
, Jayalekshmi Archa Rajagopal, Lekshmy RajagopalJ Obes Metab Syndr 2021; 30(1): 4-11
12
3616
1381
Original Article 2020-09-30
Effects of 6 Months of Dapagliflozin Treatment on Metabolic Profile and Endothelial Cell Dysfunction for Obese Type 2 Diabetes Mellitus Patients without Atherosclerotic Cardiovascular Disease
Ju-Young Hong, Keun-Young Park, Jong-Dai Kim, Won-Min Hwang, Dong-Mee Lim
J Obes Metab Syndr 2020; 29(3): 215-221
1
2450
719
Original Article 2020-06-30
Examination of Patients’ Regular Participation at an Obesity Center to Evaluate the Effects on Mental Status and Blood Parameters
Duygu İlke Yıldırım , Mehmet Ali Eryılmaz, Memduha Aydın
, Mehmet Ali Eryılmaz, Memduha AydınJ Obes Metab Syndr 2020; 29(2): 150-157
16
4348
2460
Review 2020-06-30
.jpg)
Current Long-Term Pharmacotherapies for the Management of Obesity
Bo-Yeon Kim, Seon Mee Kang, Jee-Hyun Kang, Kyoung Kon Kim, Bomtaeck Kim, Seung Jun Kim, Yang-Hyun Kim, Jung-Hwan Kim, Jae Hyun Kim, Ga Eun Nam, Ji Yeon Park, Jang Won Son, Hye-Jung Shin, Tae Jung Oh, Hyug Lee, Eon-Ju Jeon, Sochung Chung, Yong Hee Hong, Chong Hwa Kim , Committee of Clinical Practice Guidelines, Korean Society for the Study of Obesity (KSSO)
, Committee of Clinical Practice Guidelines, Korean Society for the Study of Obesity (KSSO)J Obes Metab Syndr 2020; 29(2): 99-109
15
3306
1014
Original Article 2019-12-30
Effect of Sodium-Glucose Cotransporter-2 Inhibitors versus Dipeptidyl Peptidase 4 Inhibitors on Cardiovascular Function in Patients with Type 2 Diabetes Mellitus and Coronary Artery Disease
Sook Jung Lee, Kook Hyung Lee, Hyun Geong Oh, Hye Ji Seo, Soo Jin Jeong, Chong Hwa Kim
J Obes Metab Syndr 2019; 28(4): 254-261
50
5686
2603
Review 2019-12-30
Effect of Diet on the Gut Microbiota Associated with Obesity
Bohkyung Kim, Ha-Neul Choi, Jung-Eun Yim
J Obes Metab Syndr 2019; 28(4): 216-224
15
4252
1793
Review 2019-09-30
The Role of Anti-Obesity Medication in Prevention of Diabetes and Its Complications
Tae Jung Oh
J Obes Metab Syndr 2019; 28(3): 158-166
7
3087
1108
Original Article 2019-06-30
Zaluzanin C Inhibits Differentiation of 3T3-L1 Preadipocytes into Mature Adipocytes
Sang Hee Kwak, Yoon Hee Kim
J Obes Metab Syndr 2019; 28(2): 105-111
14
3332
1312
Review 2019-03-30
The Effects of Hypoglycemic Agents on Non-alcoholic Fatty Liver Disease: Focused on Sodium-Glucose Cotransporter 2 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists
Chan-Hee Jung, Ji-Oh Mok
J Obes Metab Syndr 2019; 28(1): 18-29
June, 2024
Mostly popular keywords
About the JOMES
Article
Online First
Subjects
For Contributors
-
e-Submission
Online ISSN : 2508-7576Print ISSN : 2508-6235
© Korean Society for the Study of Obesity.
Room 1010, Renaissance Tower Bldg., 14, Mallijae-ro, Mapo-gu, Seoul 04195, Korea.
Tel: +82-2-364-0886 Fax: +82-2-364-0883 E-mail: journal@jomes.org
Powered by INFOrang Co., Ltd